Sylvain has occupied the CFO chair since 2021, having first joined the biosensing-technology firm in 2018. By merging the financial and operational mandates, DexCom intends to streamline the execution of its long-term development strategy. This consolidation places the company’s manufacturing standards and global supply chain directly under the purview of its top financial executive.
DexCom CFO Jereme Sylvain Expands Role to Chief Operating Officer
Jereme Sylvain, the financial architect behind DexCom’s recent expansion, is adding oversight of global operations and quality control to his portfolio. The company confirmed Monday that its executive vice president will now serve as both chief financial officer and chief operating officer, consolidating leadership ahead of its next growth phase.
Comments (0)
No comments yet. Be the first!